We are developing a bacterial-spore based drug delivery platform that targets solid tumors without exposing the rest of the body. This delivery platform allows us to target previously undruggable immune pathways that cannot be addressed by other (current) modalities.
San Diego, California, United States
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.